Published in Eur Urol on September 05, 2012
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Canadian guidelines for the management of small renal masses (SRM). Can Urol Assoc J (2015) 1.07
Histotripsy methods in mechanical disintegration of tissue: towards clinical applications. Int J Hyperthermia (2015) 0.99
Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus. Can Urol Assoc J (2014) 0.93
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int (2013) 0.90
Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol (2016) 0.89
What matters when selecting candidates for renal ablation: tumor size or the patient's condition? Cent European J Urol (2015) 0.88
The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol (2014) 0.87
Ablative therapies for small renal tumours. Nat Rev Urol (2013) 0.85
Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients. Eur Radiol (2015) 0.84
Comparison of laparoscopic radiofrequency ablation and open partial nephrectomy in patients with a small renal mass. Korean J Urol (2013) 0.81
What is the contemporary role of radiofrequency ablation in the management of small renal masses? Are small lesions the radiologist's tumors? Eur Urol (2012) 0.81
Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment. Medicine (Baltimore) (2016) 0.77
Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project. World J Urol (2016) 0.77
Safety and feasibility of radiofrequency ablation for treatment of Bosniak IV renal cysts. Int Braz J Urol (2016) 0.76
Cancer survivors' perspectives and experience on western medicine and traditional Chinese medicine treatment and rehabilitation: a qualitative study. Patient Prefer Adherence (2014) 0.76
Irreversible electroporation of small renal masses: suboptimal oncologic efficacy in an early series. World J Urol (2017) 0.76
CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes. Korean J Radiol (2016) 0.75
Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma. Rare Tumors (2015) 0.75
Indications for biopsy and the current status of focal therapy for renal tumours. Transl Androl Urol (2015) 0.75
Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends. Indian J Surg Oncol (2016) 0.75
Expanding thermal ablation to the 'intermediate-sized' renal mass: clinical utility in T1b tumors. Transl Androl Urol (2017) 0.75
Ultrasound-guided radiofrequency ablation for cT1a renal masses in poor surgical candidates: mid-term, single-center outcomes. Ther Adv Med Oncol (2016) 0.75
Percutaneous Cryoablation for Renal Cell Carcinoma. J Kidney Cancer VHL (2015) 0.75
Re: Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. J Urol (2013) 0.75
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. World J Urol (2016) 0.75
Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer. Oncol Lett (2017) 0.75
Decision Making: Thermal Ablation Options for Small Renal Masses. Semin Intervent Radiol (2017) 0.75
Effects of radiofrequency radiation in the presence of gold nanoparticles for the treatment of renal cell carcinoma. J Renal Inj Prev (2016) 0.75
Renal-cell carcinoma. N Engl J Med (2005) 10.17
Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med (2008) 8.77
Bladder cancer. Lancet (2009) 4.43
Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab (2002) 3.85
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J Clin Oncol (2007) 3.65
Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol (2011) 3.17
Urine leaks and urinomas: diagnosis and imaging-guided intervention. Radiographics (2003) 2.73
Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol (2005) 2.53
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology (2003) 2.53
Acute epiploic appendagitis and its mimics. Radiographics (2005) 2.46
CT appearance of acute appendagitis. AJR Am J Roentgenol (2004) 2.39
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Clinical practice. Small renal mass. N Engl J Med (2010) 2.27
Dose-finding with two agents in Phase I oncology trials. Biometrics (2003) 2.23
National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med (2008) 2.10
Adverse effect of paroxetine on sperm. Fertil Steril (2009) 1.90
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus. Nat Biotechnol (2011) 1.79
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases. Radiology (2003) 1.78
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res (2008) 1.77
Image-guided percutaneous splenic interventions. Radiographics (2012) 1.73
Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol (2005) 1.71
Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology (2003) 1.69
Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am J Surg Pathol (2013) 1.68
Incidence of malignancy in complex cystic renal masses (Bosniak category III): should imaging-guided biopsy precede surgery? AJR Am J Roentgenol (2003) 1.68
Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68
The IR RadLex project: an interventional radiology lexicon--a collaborative project of the Radiological Society of North America and the Society of Interventional Radiology. J Vasc Interv Radiol (2008) 1.61
Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Clin Oncol (2004) 1.61
Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res (2005) 1.59
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res (2006) 1.59
Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles. Prostate (2010) 1.52
Percutaneous ablation in the kidney. Radiology (2011) 1.51
The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation. J Cyst Fibros (2013) 1.49
A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients. Res Rep Urol (2012) 1.48
Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol (2005) 1.47
Long-term outcome of excisional organ sparing surgery for carcinoma of the penis. J Urol (2011) 1.43
A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy. J Urol (2009) 1.41
Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention? BJU Int (2010) 1.40
Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer. Clin Cancer Res (2005) 1.39
Penis Transplantation: First US Experience. Ann Surg (2017) 1.38
CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics (2011) 1.36
Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol (2005) 1.34
Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol (2009) 1.34
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Sensitive multiplexed analysis of kinase activities and activity-based kinase identification. Nat Biotechnol (2009) 1.21
Radiation dose reduction with hybrid iterative reconstruction for pediatric CT. Radiology (2012) 1.19
Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol (2009) 1.18
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
Celiac plexus block: a palliative tool underused by radiologists. AJR Am J Roentgenol (2002) 1.15
Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol (2005) 1.15
Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol (2009) 1.13
Stochastic search gene suggestion: a Bayesian hierarchical model for gene mapping. Biometrics (2006) 1.13
CT-guided transgluteal drainage of deep pelvic abscesses: indications, technique, procedure-related complications, and clinical outcome. Radiographics (2002) 1.11
Percutaneous nonvascular splenic intervention: a 10-year review. AJR Am J Roentgenol (2002) 1.09
Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography. Gastrointest Endosc Clin N Am (2002) 1.08
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol (2006) 1.08
Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol (2014) 1.08
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Dropped gallstones and surgical clips after cholecystectomy: CT assessment. J Comput Assist Tomogr (2007) 1.05
Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value. PLoS One (2013) 1.05
Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology (2008) 1.04
Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression. Clin Cancer Res (2009) 1.04
Ablation of liver metastases: current status. J Vasc Interv Radiol (2010) 1.02
Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression. Cancer Biol Ther (2009) 1.02
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. J Clin Oncol (2005) 1.01
Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol (2007) 1.00
Imaging-guided percutaneous renal biopsy: rationale and approach. AJR Am J Roentgenol (2010) 0.99
The inaccessible or undrainable abscess: how to drain it. Radiographics (2004) 0.99
Complex abdominal and pelvic abscesses: efficacy of adjunctive tissue-type plasminogen activator for drainage. Radiology (2008) 0.98
Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology (2005) 0.97
Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am J Surg Pathol (2012) 0.97
Transvaginal drainage of pelvic fluid collections: results, expectations, and experience. AJR Am J Roentgenol (2008) 0.96
Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer. J Urol (2011) 0.95
Penile cancer: organ-sparing techniques. BJU Int (2014) 0.95
Development and validation of a 32-gene prognostic index for prostate cancer progression. Proc Natl Acad Sci U S A (2013) 0.95
Management of abdominal and pelvic abscesses that persist despite satisfactory percutaneous drainage catheter placement. AJR Am J Roentgenol (2010) 0.94
A decade in prostate cancer: from NMR to metabolomics. Nat Rev Urol (2011) 0.94
Sonography and sonographically guided fine-needle aspiration biopsy of the thyroid gland: indications and techniques, pearls and pitfalls. AJR Am J Roentgenol (2003) 0.94
Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol (2011) 0.94
Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension. Urology (2011) 0.92
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol (2009) 0.92
cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. Hum Mutat (2005) 0.92
Renal trauma: radiologic evaluation and percutaneous treatment of nonvascular injuries. AJR Am J Roentgenol (2002) 0.91
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens. Mol Cancer Ther (2012) 0.91
Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol (2009) 0.91
Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients. AJR Am J Roentgenol (2010) 0.91
Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1, Normal findings. AJR Am J Roentgenol (2013) 0.91
Imaging and percutaneous treatment of secondarily infected hepatic infarctions. AJR Am J Roentgenol (2008) 0.91
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease. J Transl Med (2006) 0.91
An outbreak of norovirus caused by consumption of oysters from geographically dispersed harvest sites, British Columbia, Canada, 2004. Foodborne Pathog Dis (2007) 0.90